bactrim forte tablet - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

lanoxin pg

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.0625mg; ; ; ; ; digoxin 0.0625mg - tablet - 0.0625 mg - active: digoxin 0.0625mg excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone pregelatinised maize starch purified water rice starch active: digoxin 0.0625mg excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

Sweden - English - Läkemedelsverket (Medical Products Agency)

bactrim 40 mg/ml + 8 mg/ml oral suspension

Philippines - English - FDA (Food And Drug Administration)

bactrimox 500mg capsule

jekk-meary pharmaceuticals - amoxicillin (as trihydrate) - capsule - 500mg

Malta - English - Medicines Authority

bactrimel, concentrate for intravenous infusion solution 96 mg/ml

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - concentrate for solution for infusion - trimethoprim 80 mg/5ml sulfamethoxazole 400 mg/5ml - antibacterials for systemic use

Malta - English - Medicines Authority

bactrimel concentrate for solution for infusion 96 mg/ml

ej busuttil ltd busuttil buildings, triq l-ghadam, central business district zone 1, birkirkara, cbd 1060, malta - concentrate for solution for infusion - trimethoprim 80 mg/5ml sulfamethoxazole 400 mg/5ml - antibacterials for systemic use